Wells Fargo’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39 Hold
65
﹤0.01% 6645
2025
Q4
$38 Hold
65
﹤0.01% 6585
2025
Q3
$22 Hold
65
﹤0.01% 6682
2025
Q2
$107 Hold
65
﹤0.01% 6473
2025
Q1
$103 Hold
65
﹤0.01% 6373
2024
Q4
$218 Hold
65
﹤0.01% 6355
2024
Q3
$122 Hold
65
﹤0.01% 6262
2024
Q2
$128 Sell
65
-109
-63% -$272 ﹤0.01% 6230
2024
Q1
$535 Buy
174
+2
+1% +$4 ﹤0.01% 6265
2023
Q4
$400 Buy
172
+67
+64% +$209 ﹤0.01% 6434
2023
Q3
$424 Buy
105
+16
+18% +$70 ﹤0.01% 6398
2023
Q2
$365 Buy
89
+2
+2% +$11 ﹤0.01% 6550
2023
Q1
$268 Hold
87
﹤0.01% 6697
2022
Q4
$235 Sell
87
-55
-39% -$220 ﹤0.01% 6575
2022
Q3
$0 Buy
142
+58
+69% +$371 ﹤0.01% 7532
2022
Q2
$0 Buy
84
+3
+4% +$25 ﹤0.01% 7651
2022
Q1
$1K Hold
81
﹤0.01% 6877
2021
Q4
$1K Buy
+81
New +$1.74K ﹤0.01% 7089
2021
Q2
Sell
-431
Closed -$53K 7563
2021
Q1
$53K Sell
431
-1,328
-75% -$193K ﹤0.01% 5793
2020
Q4
$200K Buy
1,759
+240
+16% +$30.2K ﹤0.01% 5089
2020
Q3
$181K Sell
1,519
-86
-5% -$10K ﹤0.01% 5008
2020
Q2
$200K Buy
1,605
+861
+116% +$117K ﹤0.01% 4914
2020
Q1
$143K Buy
744
+291
+64% +$91.3K ﹤0.01% 4880
2019
Q4
$152K Sell
453
-19
-4% -$6.33K ﹤0.01% 5111
2019
Q3
$152K Buy
472
+53
+13% +$17.1K ﹤0.01% 5119
2019
Q2
$180K Buy
419
+92
+28% +$45.5K ﹤0.01% 5031
2019
Q1
$184K Buy
327
+109
+50% +$52.3K ﹤0.01% 4867
2018
Q4
$64K Buy
218
+197
+938% +$88.2K ﹤0.01% 5449
2018
Q3
$15K Buy
21
+10
+91% +$6.17K ﹤0.01% 5900
2018
Q2
$6K Sell
11
-3
-21% -$2.33K ﹤0.01% 6066
2018
Q1
$38K Buy
+14
New +$34.1K ﹤0.01% 5642

Other funds holding VYNE